
Onfasprodil is negative allosteric modulator of NR2B. Onfasprodil in combination with GABA рецептор regulator has the potential for the research of Alzheimer's disease (extracted from patent CN111481543A).
Onfasprodil is negative allosteric modulator of NR2B. Onfasprodil in combination with GABA receptor regulator has the potential for the research of Alzheimer's disease (extracted from patent CN111481543A).
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.